Johnson & Johnson (JNJ) Earnings Date, Estimates & Call Transcripts $155.01 -0.39 (-0.25%) (As of 11/29/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Johnson & Johnson Latest Earnings SummaryUpcoming Q4 Earnings DateJan. 28EstimatedActual EPS (Oct. 15) $2.42 Beat By $0.21 Consensus EPS (Oct. 15) $2.21 Johnson & Johnson released Q3 2024 earnings on October 15, 2024, reporting an EPS of $2.42, which beat the consensus estimate of $2.21 by $0.21. Quarterly revenue rose 5.2% year-over-year to $22.47 billion, above analysts' expectations of $22.17 billion. With a trailing EPS of $6.91 and a P/E Ratio of 22.43, Johnson & Johnson's earnings are expected to grow 6.14% next year, from $9.93 to $10.54 per share. Conference Call TranscriptConference Call AudioEarnings Slide DeckJNJ Upcoming EarningsJohnson & Johnson's next earnings date is estimated for Tuesday, January 28, 2025, based off prior year's reporting schedules. Get Johnson & Johnson Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Johnson & Johnson and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataJNJ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JNJ Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin AnalyticsIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is making headlines for last week's new earnings report – which revealed the AI juggernaut nearly doubled their profits in the last year alone.A 50-year Wall Street veteran gives his answer Nvidia, right here... Johnson & Johnson Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$2.59$2.78$2.66 Q2 20243$2.73$2.87$2.78 Q3 20243$2.12$2.92$2.57 Q4 20243$1.96$2.80$2.36 FY 202412$9.40$11.37$10.37 Q1 20251$2.65$2.65$2.65 Q2 20251$2.72$2.72$2.72 Q3 20251$2.59$2.59$2.59 Q4 20251$2.63$2.63$2.63 FY 20254$10.59$10.59$10.59 Q1 20261$2.76$2.76$2.76 Q2 20261$2.82$2.82$2.82 Johnson & Johnson Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 1/28/2025(Estimated)------- 10/15/2024Q3 2024$2.21$2.42+$0.21$3.73$22.17B$22.47B 7/17/2024Q2 2024$2.71$2.82+$0.11$3.71$22.33B$22.45B 4/16/2024Q1 2024$2.64$2.71+$0.07$3.22$21.39B$21.38B 1/23/2024Q4 2023$2.28$2.29+$0.01$2.91$21.02B$21.40B 10/17/2023Q3 2023$2.52$2.66+$0.14-$4.89$21.00B$21.35B 7/20/2023Q2 2023$2.62$2.80+$0.18$3.64$24.63B$25.53B Get the Latest News and Ratings for JNJ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter. 4/18/2023Q1 2023$2.51$2.68+$0.17$5.39$23.61B$24.75B 1/24/2023Q4 2022$2.22$2.35+$0.13$3.37$23.90B$23.71B Johnson & Johnson Earnings - Frequently Asked Questions When is Johnson & Johnson's earnings date? Johnson & Johnson has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 28th, 2025 based off last year's report dates. Learn more on JNJ's earnings history. What guidance has Johnson & Johnson issued on next quarter's earnings? Johnson & Johnson updated its FY24 earnings guidance on Tuesday, October, 15th. The company provided earnings per share guidance of $9.88-9.98 for the period, compared to the consensus EPS estimate of $9.95. The company issued revenue guidance of $88.4-88.8 billion, compared to the consensus revenue estimate of $88.51 billion. Did Johnson & Johnson beat their earnings estimates last quarter? In the previous quarter, Johnson & Johnson (NYSE:JNJ) reported $2.42 earnings per share (EPS) to beat the analysts' consensus estimate of $2.21 by $0.21. Learn more on analysts' earnings estimate vs. JNJ's actual earnings. How can I listen to Johnson & Johnson's earnings conference call? The conference call for Johnson & Johnson's latest earnings report can be listened to online. Listen to Conference Call How can I read Johnson & Johnson's conference call transcript? The conference call transcript for Johnson & Johnson's latest earnings report can be read online. Read Transcript How much revenue does Johnson & Johnson generate each year? Johnson & Johnson (NYSE:JNJ) has a recorded annual revenue of $87.70 billion. How much profit does Johnson & Johnson generate each year? Johnson & Johnson (NYSE:JNJ) has a recorded net income of $35.15 billion. JNJ has generated $6.91 earnings per share over the last four quarters. What is Johnson & Johnson's price-to-earnings ratio? Johnson & Johnson (NYSE:JNJ) has a trailing price-to-earnings ratio of 22.43 and a forward price-to-earnings ratio of 15.61. The price/earnings-to-growth ratio is 2.76. What is Johnson & Johnson's EPS forecast for next year? Johnson & Johnson's earnings are expected to grow from $9.93 per share to $10.54 per share in the next year, which is a 6.14% increase. ` More Earnings Resources from MarketBeat Related Companies Eli Lilly and Company Earnings AbbVie Earnings Merck & Co., Inc. Earnings Pfizer Earnings Bristol-Myers Squibb Earnings Zoetis Earnings Royalty Pharma Earnings Jazz Pharmaceuticals Earnings Corcept Therapeutics Earnings Perrigo Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Is NVDA a sell? Buy this stock instead before Dec 3 (Ad)After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is making headlines for last week's new earnings report – which revealed the AI juggernaut nearly doubled their profits in the last year alone.A 50-year Wall Street veteran gives his answer Nvidia, right here... This page (NYSE:JNJ) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredThe Trump Surge-SectorsIt's already responsible for the greatest stock market achievements in history. It predicted President Trump's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.